Mostrar el registro sencillo del ítem

dc.contributor.author
Bertolesix, Gabriel Esteban  
dc.contributor.author
Lauría de Cidre, Lilia  
dc.contributor.author
Sacerdote de Lustig, Eugenia  
dc.contributor.author
Eiján, Ana María  
dc.date.available
2021-01-13T21:44:36Z  
dc.date.issued
1995-04-14  
dc.identifier.citation
Bertolesix, Gabriel Esteban; Lauría de Cidre, Lilia; Sacerdote de Lustig, Eugenia; Eiján, Ana María; Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition; Elsevier; Cancer Letters; 90; 2; 14-4-1995; 123-131  
dc.identifier.issn
0304-3835  
dc.identifier.uri
http://hdl.handle.net/11336/122696  
dc.description.abstract
Binding of heparin to primary cultured cells of two murine mammary adenocarcinomas with low (M3) and high (MM3) lung, metastatic capacity was determined. Heparin binding was rapid, specific and saturable. MM3 cells grown for 24 h in fetal calf serum (FCS)-free medium exhibited a higher number of binding sites for 3H-heparin [(11 ± 1) × 105 sites per cell] than M3 cells [(6.9 ± 0.6) × 105 sites per cell]. However, when M3 cells were grown in the presence of 2% FCS, they showed less heparin binding sites [(3.5 ± 0.4) × 105 sites per cell]. In contrast, dissociation constants were very similar for MM3 and M3 cells grown with or without FCS (Kd = 2−4 × 10−9M). Furthermore, heparin inhibited MM3 and M3 cell growth both in the absence or presence of FCS. Competition studies showed that chemically modified heparins lacking antiproliferative effect (O-desulfated; O/N-desulfated N-acetylated and N-desulfated heparins) were not able to inhibit 3H-heparin binding. N-desulfated N-acetylated heparin, which had partial antiproliferative effect, partially inhibited 3H-heparin binding, while heparin with a high antiproliferative activity inhibited more than 90% 3H-heparin binding. The antiproliferative effect of heparin and chemically modified heparins seems to be related to their binding ability to the cell membrane.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
RECEPTOR  
dc.subject
GROWTH INHIBITION  
dc.subject
TUMOR  
dc.subject
METASTASIS  
dc.subject
HEPARIN  
dc.subject
SACERDOTE INVESTIGADORA  
dc.subject
PUBLICACIONES  
dc.subject.classification
Oncología  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition  
dc.type
info:eu-repo/semantics/article  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.journal.volume
90  
dc.journal.number
2  
dc.journal.pagination
123-131  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Ámsterdam  
dc.description.fil
Fil: Bertolesix, Gabriel Esteban. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina  
dc.description.fil
Fil: Lauría de Cidre, Lilia. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Biodiversidad y Biología Experimental. Laboratorio de Histología Animal; Argentina  
dc.description.fil
Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Eiján, Ana María. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina  
dc.journal.title
Cancer Letters  
dc.provenance
Otro  
dc.format.espacioDeColor
EscalaGris  
dc.format.compresion
No especifica  
dc.description.nivelDescripcion
Unidad documental simple  
dc.type.subtype
Artículo científico  
dc.type
info:ar-repo/semantics/artículo